[HTML][HTML] A selenium containing inhibitor for the treatment of hepatocellular cancer
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer
HRS Tagaram, D Desai, G Li, D Liu… - …, 2016 - search.proquest.com
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
A selenium containing inhibitor for the treatment of hepatocellular cancer
HRS Tagaram, D Desai, G Li, D Liu, CB Rountree… - …, 2016 - pure.psu.edu
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
[PDF][PDF] A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer
HRS Tagaram, D Desai, G Li, D Liu… - …, 2016 - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.
HRS Tagaram, D Desai, G Li, D Liu… - Pharmaceuticals …, 2016 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
[HTML][HTML] A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer
HRS Tagaram, D Desai, G Li, D Liu, CB Rountree… - …, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer
HRS Tagaram, D Desai, G Li, D Liu… - Pharmaceuticals …, 2016 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
[PDF][PDF] A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer
HRS Tagaram, D Desai, G Li, D Liu, CB Rountree… - …, 2016 - academia.edu
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer.
HR Tagaram, D Desai, G Li, D Liu… - Pharmaceuticals …, 2016 - europepmc.org
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment
strategies are desperately needed due to limited standard therapies. Activation of the Erk …
strategies are desperately needed due to limited standard therapies. Activation of the Erk …